Supporting Clinical Research
Provocholine®
Aridol®
Partnerships
Training
Clinical Research Consultation
CRCE Courses
Blogs / Podcast
Guidelines / Publications
Speaking Engagements
Research is the key to better respiratory care
Airway challenge tests are objective measures that offer insight into investigational drugs. For over 30 years, these tests have been part of clinical trials as a means to identify the appropriate patient populations, assess response to therapies, and evaluate bioequivalence. Objective measures are more relevant than ever with the emergence and growth of specialized pharmacologic treatments such as biologics for respiratory conditions.
We are the globally trusted partner in methacholine challenge testing.
Methapharm offers products and consultative services to support your clinical respiratory research that incorporates bronchial challenge testing.
Products
Services
Onsite and virtual training on bronchial challenge testing by clinical specialists
Support in the development and review of study protocols
Support in determining product volumes required
Full-service logistics and regulatory documentation
Legend
Asthma
FeNO
Provocholine
Publications
Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma. Pavord, 2023
Early effectiveness of type-2 severe asthma treatment with dupilumab in a real-life setting; a FeNO-driven choice that leads to winning management. Carpagnano, 2022
Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses. Gauvreau, 2014
FDA Draft Guidance on Albuterol Sulfate, Mar 2020
Clinical equivalence testing of inhaled bronchodilators. Nair, 2009
We invite you to contact us at 1-800-287-7686 or via Email.